Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ken Stein

Showing results (31-40 of 100) with videos related to

Pageof 10
Sort By:
The Cochrane Database of Systematic Reviews|May 2, 2013
Temozolomide for high grade gliomaMichael G Hart, Ruth Garside, Gabriel Rogers, et al.
BMJ (Clinical Research Ed.)|February 26, 2005
Efficacy and tolerability of topical pimecrolimus and tacrolimus in the treatment of atopic dermatitis: meta-analysis of randomised controlled trialsDarren M Ashcroft, Paul Dimmock, Ruth Garside, et al.
Journal of Hepatology|October 22, 2003
Screening for hepatitis C in genito-urinary medicine clinics: a cost utility analysisKen Stein, Kim Dalziel, Andrew Walker, et al.
Journal of Safety Research|December 14, 2011
Implementing the evidence for preventing falls among community-dwelling older people: a systematic reviewVictoria Goodwin, Tracey Jones-Hughes, Jo Thompson-Coon, et al.
Pharmacoeconomics|June 16, 2017
Informing Reimbursement Decisions Using Cost-Effectiveness Modelling: A Guide to the Process of Generating Elicited Priors to Capture Model UncertaintiesLaura Bojke, Bogdan Grigore, Dina Jankovic, et al.
BMJ Open|December 17, 2017
Feasibility of a hyper-acute stroke unit model of care across England: a modelling analysisMichael Allen, Kerry Pearn, Emma Villeneuve, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 20, 2007
The cost-utility of cinacalcet in addition to standard care compared to standard care alone for secondary hyperparathyroidism in end-stage renal disease: a UK perspectiveRuth Garside, Martin Pitt, Rob Anderson, et al.
Journal of Public Health (Oxford, England)|March 27, 2004
Screening for Hepatitis C in injecting drug users: a cost utility analysisKen Stein, Kim Dalziel, Andrew Walker, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|March 4, 2009
The precision of health state valuation by members of the general public using the standard gambleKen Stein, Matthew Dyer, Ruairidh Milne, et al.
The Cochrane Database of Systematic Reviews|October 10, 2008
Temozolomide for high grade gliomaMichael G Hart, Robert Grant, Ruth Garside, et al.
Pageof 10

Showing results (31-40 of 100) with videos related to

Sort By:
Pageof 10
The Cochrane Database of Systematic Reviews|May 2, 2013
Temozolomide for high grade gliomaMichael G Hart, Ruth Garside, Gabriel Rogers, et al.
BMJ (Clinical Research Ed.)|February 26, 2005
Efficacy and tolerability of topical pimecrolimus and tacrolimus in the treatment of atopic dermatitis: meta-analysis of randomised controlled trialsDarren M Ashcroft, Paul Dimmock, Ruth Garside, et al.
Journal of Hepatology|October 22, 2003
Screening for hepatitis C in genito-urinary medicine clinics: a cost utility analysisKen Stein, Kim Dalziel, Andrew Walker, et al.
Journal of Safety Research|December 14, 2011
Implementing the evidence for preventing falls among community-dwelling older people: a systematic reviewVictoria Goodwin, Tracey Jones-Hughes, Jo Thompson-Coon, et al.
Pharmacoeconomics|June 16, 2017
Informing Reimbursement Decisions Using Cost-Effectiveness Modelling: A Guide to the Process of Generating Elicited Priors to Capture Model UncertaintiesLaura Bojke, Bogdan Grigore, Dina Jankovic, et al.
BMJ Open|December 17, 2017
Feasibility of a hyper-acute stroke unit model of care across England: a modelling analysisMichael Allen, Kerry Pearn, Emma Villeneuve, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 20, 2007
The cost-utility of cinacalcet in addition to standard care compared to standard care alone for secondary hyperparathyroidism in end-stage renal disease: a UK perspectiveRuth Garside, Martin Pitt, Rob Anderson, et al.
Journal of Public Health (Oxford, England)|March 27, 2004
Screening for Hepatitis C in injecting drug users: a cost utility analysisKen Stein, Kim Dalziel, Andrew Walker, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|March 4, 2009
The precision of health state valuation by members of the general public using the standard gambleKen Stein, Matthew Dyer, Ruairidh Milne, et al.
The Cochrane Database of Systematic Reviews|October 10, 2008
Temozolomide for high grade gliomaMichael G Hart, Robert Grant, Ruth Garside, et al.
Pageof 10